Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

[EX Q]: In October 2018, a warning appeared and made its way around the usual internet circles to warn against eating meat from deer afflicted with “bovine tuberculosis.” The warning was accompanied by a rather unappetizing photograph of a lesion-studded hunk of meat that showed what people should avoid:Since 1995, Michigan has been testing white-tailed deer for bovine tuberculosis year-round. Michigan has the longest- running continuous wildlife TB surveillance program in the world.“Most Michiganders, and even most policymakers, don’t realize how much we’ve learned about bTB in the last 20 years”, said Dan O’Brien, veterinary specialist with DNR’s wildlife disease lab. “The research we’ve done here in Michigan is respected around the world.“Other countries dealing with similar outbreaks of bTB continue to watch our situation with great interest. At this point, we know what it will take to get rid of bTB. Whether we as a state will choose to make that happen though is still an open question.”The original warning was belched back into the public consciousness in October 2018 because a large cattle herd in Alcona County was found to be infected with bovine tuberculosis, the 73rd herd so infected since 1998:Bovine TB is a bacterial disease that also has infected free-ranging whitetail deer in parts of the northeastern Lower Peninsula.Cattle in Alcona, Alpena, Montmorency and Oscoda counties must be tested before they are moved off the farm, which can help prevent the illness from spreading.Assistant State Veterinarian Nancy Barr says farmers in that area should do all they can to prevent deer from having contact with cattle feeding and watering areas.The original warning simply urges hunters to get the wild deer they kill tested free of charge before consumption, even if it looks healthy. Humans as well as cattle can potentially contract bovine tuberculosis, which is relatively rare, but potentially fatal if left untreated.
[EX A]: "Bovine tuberculosis"" has appeared in a herd of cattle in Michigan."

[EX Q]: Scientists dubbed the startling findings “immune amnesia.” The body can rebuild those defenses — but it could take years. And with measles on the rise, “it should be a scary phenomenon,” said Dr. Michael Mina of Harvard’s school of public health, lead author of research published Thursday in the journal Science. “This goes under the radar” because doctors wouldn’t necessarily connect a child’s pneumonia to measles they suffered a year earlier, Mina explained. “But would they have gotten it if they hadn’t gotten measles?” The Harvard team analyzed blood samples taken from 77 children before and after a measles outbreak in an unvaccinated community in the Netherlands. They looked for antibodies, which remember viruses and bacteria they encounter to guard against a repeat infection. After recovering from measles, the youngsters were left with plenty of antibodies against that virus — but ones they’d previously harbored against other germs had plummeted. In the most severe cases, “they’re just as vulnerable as if they were infants,” said study senior author Stephen Elledge, a Harvard geneticist. Elledge is paid by the Howard Hughes Medical Institute, which also supports AP’s Health & Science Department. A separate study, published Thursday in Science Immunology, supported the findings. Researchers from Britain’s Wellcome Sanger Institute used the Dutch blood samples to genetically test antibody-producing cells, and concluded measles is eliminating enough to re-set the immune system to a baby-like state. If protection against the misery — and sometimes life-threatening effects — of measles isn’t enough reason to vaccinate children, specialists said the two studies offer a powerful new rationale. “There really are profound gaps and holes” in someone’s immunity after measles, said Dr. Anthony Fauci of the U.S. National Institutes of Health, which helped fund the Harvard work. “You ultimately recover but after a year or two or sometimes more.” “It’s doubly important to vaccinate children,” agreed Dr. Mark Mulligan of NYU Langone Health, who wasn’t involved with the new research. “It’s a vaccine that protects against the specific target, measles virus, but also against immune suppression.” Measles is one of the world’s most contagious viruses, able to spread through coughs and sneezes for four days before someone develops the characteristic rash. It sometimes leaves children with brain damage or hearing loss, and while deaths are rare in the U.S., measles killed 110,000 people globally in 2017. The vaccine offers powerful protection but a lack of access means measles remains rampant in many lower-income countries. Even the U.S., where most children are immunized, has seen a resurgence fueled by outbreaks in unvaccinated communities that in turn threaten people too young or sick to be immunized. So far this year, the Centers for Disease Control and Prevention has counted more than 1,200 U.S. measles cases, the most since 1992. Doctors have long known that people temporarily experience weakened immunity after measles. Using decades of health records, Mina previously reported that child deaths from other infections jumped after a measles outbreak, increases that lasted two or three years. But no one knew why, until the new study. The Dutch children started out pretty healthy: Technology developed in Elledge’s lab found antibodies in their blood against typical childhood germs. But two months after recovering from measles, the children had lost on average 20 percent of their usual antibody mix. Some lost up to 70 percent of protection against specific bugs, limiting their ability to respond if they encounter that germ again. Importantly, researchers didn’t find loss of antibodies in “control” populations that didn’t get infected with measles — or in children after they received the measles vaccine. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.
[EX A]: Measles saps kids’ ability to fight other germs.

[EX Q]: A researcher archives plasma samples from an HIV clinical trial in a file photo. A gel that uses a popular HIV drug to protect women from the AIDS virus is safe and acceptable to women, although it is too early to know if it actually prevents infection, researchers reported on Monday. REUTERS/Tim Wimborne The gel uses the drug tenofovir, sold under the name Viread by Gilead Sciences Inc.. The study, released at a meeting of AIDS researchers in India, is a welcome piece of good news for the struggling field of microbicides. It involved 200 sexually active HIV-negative women in the United States and India. “The gel is safe to use, and well tolerated by HIV-negative women. That’s a key message in our findings,” said Dr. Craig Hoesley of the University of Alabama at Birmingham. “This sets the stage for larger studies to see if tenofovir can prevent HIV infection.”   Microbicides are products, such as gels or creams, that can be applied vaginally or anally to prevent transmission of the human immunodeficiency virus that causes AIDS. Just last week a study showed one candidate, called Carraguard, did not protect women from infection. Two other potential microbicides have made women more likely to become infected — a spermicide called nonoxynol-9 and a product called Ushercell, made by Toronto, Canada-based Polydex Pharmaceuticals. The tenofovir product appears to be safe, said the research team, funded by the National Institutes of Health, found. It is the first potential microbicide to use a licensed AIDS drug. It was a phase II clinical trial designed to show safety, not that it was effective. “It is a critical time for all of us engaged in HIV prevention, and I truly believe we are turning a corner,” said Sharon Hillier of the University of Pittsburgh School of Medicine, who led the study. Women make up 46 percent of the 33.2 million people infected with the AIDS virus, according to the United Nations Agency UNAIDS. Hillier said it is not clear how long tenofovir stays in a woman’s vagina. “Currently, there are very encouraging studies suggesting that even when tenofovir is gone from the vagina the drug itself is there in the vaginal tissue,” Hillier said in an e-mail. “The important thing we learned is that covert use, or secret use, is not an important parameter for women, and that in fact we found that 12 percent of the women who used to the gel said it made sex more pleasurable and none of the women said that the gel made sex less pleasurable.”   Eighty percent of the women told to use gel within two hours of having sex said they had done so. “We asked women ‘How acceptable is this as a prevention option, is it too messy, is it a nuisance, and will you use it?’ Our study showed they will use it and they’re not bothered by the gel,” Hoesley said.
[EX A]:
Tests of new AIDS gel show promise for women.